SK
Sajan Kumar Agarwal
About Sajan Kumar Agarwal
Data last updated:
Sajan Kumar Agarwal is a Director at Hyperion Pharma Co Private Limited (since 2014). The company operates in Trading. Hyperion Pharma Co Private Limited reported revenue of ₹19.6 Lakh (FY 2020).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 16 Jul 2014 | 2014 | ₹19.6 Lakh (FY 2020) | Active |
Board colleagues of Sajan Kumar Agarwal
| Name | DIN | Company | Designation |
|---|---|---|---|
| Jiwan Agarwala | 07014007 | Hyperion Pharma Co Private Limited | Director |
| Nitu Garg Agarwal | 06838153 | Hyperion Pharma Co Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Sajan Kumar Agarwal
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sajan Kumar Agarwal
Sajan Kumar Agarwal currently holds 1 directorship: Hyperion Pharma Co Private Limited (Director, since 16 Jul 2014, revenue ₹19.6 Lakh (FY 2020)).
Sajan Kumar Agarwal was first appointed on 16 Jul 2014 as Director at Hyperion Pharma Co Private Limited.
The current boards of Sajan Kumar Agarwal's companies include Jiwan Agarwala (Hyperion Pharma Co Private Limited), Nitu Garg Agarwal (Hyperion Pharma Co Private Limited).